An in vivo and in vitro model of Plasmodium falciparum rosetting and autoagglutination mediated by varO, a group A var gene encoding a frequent serotype.

PubWeight™: 1.45‹?› | Rank: Top 5%

🔗 View Article (PMC 2583593)

Published in Infect Immun on September 22, 2008

Authors

Inès Vigan-Womas1, Micheline Guillotte, Cécile Le Scanf, Sébastien Igonet, Stéphane Petres, Alexandre Juillerat, Cyril Badaut, Farida Nato, Achim Schneider, Anne Lavergne, Hugues Contamin, Adama Tall, Laurence Baril, Graham A Bentley, Odile Mercereau-Puijalon

Author Affiliations

1: Institut Pasteur, Unité d'Immunologie Moléculaire des Parasites, CNRS URA 2581, 25 rue du Dr Roux, F-75724 Paris, France. ines.vigan-womas@pasteur.fr

Articles citing this

A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature (2013) 11.03

Plasmodium falciparum erythrocyte membrane protein 1 diversity in seven genomes--divide and conquer. PLoS Comput Biol (2010) 2.80

Adhesion of Plasmodium falciparum-infected erythrocytes to human cells: molecular mechanisms and therapeutic implications. Expert Rev Mol Med (2009) 2.77

A subset of group A-like var genes encodes the malaria parasite ligands for binding to human brain endothelial cells. Proc Natl Acad Sci U S A (2012) 1.99

Investigating the host binding signature on the Plasmodium falciparum PfEMP1 protein family. PLoS Pathog (2011) 1.53

The sensing of poorly deformable red blood cells by the human spleen can be mimicked in vitro. Blood (2010) 1.52

Evasion of Immunity to Plasmodium falciparum: Rosettes of Blood Group A Impair Recognition of PfEMP1. PLoS One (2015) 1.43

Induction of strain-transcending antibodies against Group A PfEMP1 surface antigens from virulent malaria parasites. PLoS Pathog (2012) 1.35

Structural basis for the ABO blood-group dependence of Plasmodium falciparum rosetting. PLoS Pathog (2012) 1.27

Prognostic indicators of life-threatening malaria are associated with distinct parasite variant antigen profiles. Sci Transl Med (2012) 1.27

Structure of a Plasmodium falciparum PfEMP1 rosetting domain reveals a role for the N-terminal segment in heparin-mediated rosette inhibition. Proc Natl Acad Sci U S A (2011) 1.22

Allelic diversity of the Plasmodium falciparum erythrocyte membrane protein 1 entails variant-specific red cell surface epitopes. PLoS One (2011) 1.07

Immunisation with recombinant PfEMP1 domains elicits functional rosette-inhibiting and phagocytosis-inducing antibodies to Plasmodium falciparum. PLoS One (2011) 1.01

var gene transcription and PfEMP1 expression in the rosetting and cytoadhesive Plasmodium falciparum clone FCR3S1.2. Malar J (2011) 1.01

Antibodies to a full-length VAR2CSA immunogen are broadly strain-transcendent but do not cross-inhibit different placental-type parasite isolates. PLoS One (2011) 1.00

Evolution of the multi-domain structures of virulence genes in the human malaria parasite, Plasmodium falciparum. PLoS Comput Biol (2012) 0.97

Plasmodium falciparum rosetting epitopes converge in the SD3-loop of PfEMP1-DBL1α. PLoS One (2012) 0.95

Transfer of 4-hydroxynonenal from parasitized to non-parasitized erythrocytes in rosettes. Proposed role in severe malaria anemia. Br J Haematol (2012) 0.88

Investigating the function of Fc-specific binding of IgM to Plasmodium falciparum erythrocyte membrane protein 1 mediating erythrocyte rosetting. Cell Microbiol (2015) 0.88

α2-Macroglobulin Can Crosslink Multiple Plasmodium falciparum Erythrocyte Membrane Protein 1 (PfEMP1) Molecules and May Facilitate Adhesion of Parasitized Erythrocytes. PLoS Pathog (2015) 0.87

Analysis of antibody induction upon immunization with distinct NTS-DBL1α-domains of PfEMP1 from rosetting Plasmodium falciparum parasites. Malar J (2013) 0.86

Insight into antigenic diversity of VAR2CSA-DBL5ε domain from multiple Plasmodium falciparum placental isolates. PLoS One (2010) 0.86

A sequence in subdomain 2 of DBL1α of Plasmodium falciparum erythrocyte membrane protein 1 induces strain transcending antibodies. PLoS One (2013) 0.85

The effect of anti-rosetting agents against malaria parasites under physiological flow conditions. PLoS One (2013) 0.83

Malaria and human red blood cells. Med Microbiol Immunol (2012) 0.83

Global selection of Plasmodium falciparum virulence antigen expression by host antibodies. Sci Rep (2016) 0.82

The humoral response to Plasmodium falciparum VarO rosetting variant and its association with protection against malaria in Beninese children. Malar J (2010) 0.81

B-cell epitopes in NTS-DBL1α of PfEMP1 recognized by human antibodies in Rosetting Plasmodium falciparum. PLoS One (2014) 0.80

Comparative analysis of IgG responses to Plasmodium falciparum MSP1p19 and PF13-DBL1α1 using ELISA and a magnetic bead-based duplex assay (MAGPIX®-Luminex) in a Senegalese meso-endemic community. Malar J (2014) 0.80

Binding of subdomains 1/2 of PfEMP1-DBL1α to heparan sulfate or heparin mediates Plasmodium falciparum rosetting. PLoS One (2015) 0.80

Analysis of antibody profiles in symptomatic malaria in three sentinel sites of Ivory Coast by using multiplex, fluorescent, magnetic, bead-based serological assay (MAGPIX™). Malar J (2015) 0.78

Multiple Plasmodium falciparum Erythrocyte Membrane Protein 1 Variants per Genome Can Bind IgM via Its Fc Fragment Fcμ. Infect Immun (2015) 0.78

Immunogenicity of the Plasmodium falciparum PfEMP1-VarO Adhesin: Induction of Surface-Reactive and Rosette-Disrupting Antibodies to VarO Infected Erythrocytes. PLoS One (2015) 0.76

Functional analysis of monoclonal antibodies against the Plasmodium falciparum PfEMP1-VarO adhesin. Malar J (2016) 0.75

Epitopes of anti-RIFIN antibodies and characterization of rif-expressing Plasmodium falciparum parasites by RNA sequencing. Sci Rep (2017) 0.75

Articles cited by this

Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19

Human malaria parasites in continuous culture. Science (1976) 59.70

Genome sequence of the human malaria parasite Plasmodium falciparum. Nature (2002) 37.89

The large diverse gene family var encodes proteins involved in cytoadherence and antigenic variation of Plasmodium falciparum-infected erythrocytes. Cell (1995) 10.35

Selective upregulation of a single distinctly structured var gene in chondroitin sulphate A-adhering Plasmodium falciparum involved in pregnancy-associated malaria. Mol Microbiol (2003) 6.04

Combating malaria morbidity and mortality by reducing transmission. Parasitol Today (1996) 5.40

P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Nature (1997) 4.84

Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet (1990) 4.58

A genome-wide map of diversity in Plasmodium falciparum. Nat Genet (2006) 4.50

Antigenic variation in malaria: in situ switching, relaxed and mutually exclusive transcription of var genes during intra-erythrocytic development in Plasmodium falciparum. EMBO J (1998) 4.40

The Dielmo project: a longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal. Am J Trop Med Hyg (1994) 4.34

Genome variation and evolution of the malaria parasite Plasmodium falciparum. Nat Genet (2006) 3.68

Plasmodium falciparum associated with severe childhood malaria preferentially expresses PfEMP1 encoded by group A var genes. J Exp Med (2004) 3.63

Sub-grouping of Plasmodium falciparum 3D7 var genes based on sequence analysis of coding and non-coding regions. Malar J (2003) 3.57

Plasmodium falciparum rosetting is associated with malaria severity in Kenya. Infect Immun (1995) 3.20

A family affair: var genes, PfEMP1 binding, and malaria disease. Curr Opin Microbiol (2006) 2.93

Classification of adhesive domains in the Plasmodium falciparum erythrocyte membrane protein 1 family. Mol Biochem Parasitol (2000) 2.86

Identification of Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) as the rosetting ligand of the malaria parasite P. falciparum. J Exp Med (1998) 2.83

Structural basis for Duffy recognition by the malaria parasite Duffy-binding-like domain. Nature (2005) 2.63

Antibody recognition of Plasmodium falciparum erythrocyte surface antigens in Kenya: evidence for rare and prevalent variants. Infect Immun (1999) 2.62

Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3. PLoS Med (2007) 2.54

Widespread functional specialization of Plasmodium falciparum erythrocyte membrane protein 1 family members to bind CD36 analysed across a parasite genome. Mol Microbiol (2003) 2.46

Plasmodium falciparum variant surface antigen expression varies between isolates causing severe and nonsevere malaria and is modified by acquired immunity. J Immunol (2002) 2.39

Plasmodium falciparum: the human agglutinating antibody response to the infected red cell surface is predominantly variant specific. Exp Parasitol (1992) 2.38

Platelet-mediated clumping of Plasmodium falciparum-infected erythrocytes is a common adhesive phenotype and is associated with severe malaria. Proc Natl Acad Sci U S A (2001) 2.27

Patterns of gene recombination shape var gene repertoires in Plasmodium falciparum: comparisons of geographically diverse isolates. BMC Genomics (2007) 2.23

Differential var gene transcription in Plasmodium falciparum isolates from patients with cerebral malaria compared to hyperparasitaemia. Mol Biochem Parasitol (2006) 2.22

Identification of a Plasmodium falciparum intercellular adhesion molecule-1 binding domain: a parasite adhesion trait implicated in cerebral malaria. Proc Natl Acad Sci U S A (2000) 2.19

Rosetting of Plasmodium falciparum-infected red blood cells with uninfected red blood cells enhances microvascular obstruction under flow conditions. Blood (1991) 2.18

The semiconserved head structure of Plasmodium falciparum erythrocyte membrane protein 1 mediates binding to multiple independent host receptors. J Exp Med (2000) 2.15

Plasmodium falciparum variant surface antigen expression patterns during malaria. PLoS Pathog (2005) 2.13

Separation of malaria-infected erythrocytes from whole blood: use of a selective high-gradient magnetic separation technique. Lancet (1981) 2.06

Rosette formation in Plasmodium falciparum isolates and anti-rosette activity of sera from Gambians with cerebral or uncomplicated malaria. Am J Trop Med Hyg (1992) 2.06

A study of var gene transcription in vitro using universal var gene primers. Mol Biochem Parasitol (2000) 1.92

Virulence of malaria is associated with differential expression of Plasmodium falciparum var gene subgroups in a case-control study. J Infect Dis (2006) 1.89

Fresh isolates from children with severe Plasmodium falciparum malaria bind to multiple receptors. Infect Immun (2001) 1.72

Isolation of multiple sequences from the Plasmodium falciparum genome that encode conserved domains homologous to those in erythrocyte-binding proteins. Proc Natl Acad Sci U S A (1995) 1.69

Multiple adhesive phenotypes linked to rosetting binding of erythrocytes in Plasmodium falciparum malaria. Infect Immun (1998) 1.68

Novel fibrillar structure confers adhesive property to malaria-infected erythrocytes. Nat Med (1996) 1.60

Antigenic variation in Plasmodium falciparum: gene organization and regulation of the var multigene family. Eukaryot Cell (2007) 1.58

A comparison of methods used for the removal of white cells from malaria-infected blood. Ann Trop Med Parasitol (1976) 1.54

Natural protection against severe Plasmodium falciparum malaria due to impaired rosette formation. Blood (1994) 1.54

Baculovirus-expressed constructs induce immunoglobulin G that recognizes VAR2CSA on Plasmodium falciparum-infected erythrocytes. Infect Immun (2006) 1.53

Malaria surveillance counts. Am J Trop Med Hyg (2007) 1.52

Nonimmune IgM, but not IgG binds to the surface of Plasmodium falciparum-infected erythrocytes and correlates with rosetting and severe malaria. Am J Trop Med Hyg (2002) 1.51

Mapping of the region of complement receptor (CR) 1 required for Plasmodium falciparum rosetting and demonstration of the importance of CR1 in rosetting in field isolates. J Immunol (2000) 1.48

Expression of Plasmodium falciparum erythrocyte membrane protein 1 in experimentally infected humans. Malar J (2005) 1.48

PfEMP1-DBL1alpha amino acid motifs in severe disease states of Plasmodium falciparum malaria. Proc Natl Acad Sci U S A (2007) 1.47

Production and characterization of neutralizing and nonneutralizing monoclonal antibodies against listeriolysin O. Infect Immun (1991) 1.47

Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use. PLoS One (2007) 1.44

The crystal structure of C-terminal merozoite surface protein 1 at 1.8 A resolution, a highly protective malaria vaccine candidate. Mol Cell (1999) 1.40

var genes, PfEMP1 and the human host. Mol Biochem Parasitol (2004) 1.34

Low multiplication rates of African Plasmodium falciparum isolates and lack of association of multiplication rate and red blood cell selectivity with malaria virulence. Am J Trop Med Hyg (2006) 1.33

Short report: Positive correlation between rosetting and parasitemia in Plasmodium falciparum clinical isolates. Am J Trop Med Hyg (2002) 1.31

Differential var gene expression in the organs of patients dying of falciparum malaria. Mol Microbiol (2007) 1.22

An approach to classifying sequence tags sampled from Plasmodium falciparum var genes. Mol Biochem Parasitol (2007) 1.21

Immunization with PfEMP1-DBL1alpha generates antibodies that disrupt rosettes and protect against the sequestration of Plasmodium falciparum-infected erythrocytes. Vaccine (2004) 1.20

Human cerebral malaria: lack of significant association between erythrocyte rosetting and disease severity. Trans R Soc Trop Med Hyg (1995) 1.19

Crystal structure of a Fab complex formed with PfMSP1-19, the C-terminal fragment of merozoite surface protein 1 from Plasmodium falciparum: a malaria vaccine candidate. J Mol Biol (2003) 1.14

Platelet-induced autoagglutination of Plasmodium falciparum-infected red blood cells and disease severity in Thailand. J Infect Dis (2004) 1.12

Soluble and glyco-lipid modified baculovirus Plasmodium falciparum C-terminal merozoite surface protein 1, two forms of a leading malaria vaccine candidate. Vaccine (2006) 1.11

Autoagglutination of malaria-infected red blood cells and malaria severity. Lancet (2000) 1.08

Genetic analysis of circulating and sequestered populations of Plasmodium falciparum in fatal pediatric malaria. J Infect Dis (2006) 1.08

Immunogenicity of Duffy binding-like domains that bind chondroitin sulfate A and protection against pregnancy-associated malaria. Infect Immun (2006) 1.08

Heparan sulphate identified on human erythrocytes: a Plasmodium falciparum receptor. Biochem J (2004) 1.07

Platelet-induced clumping of Plasmodium falciparum-infected erythrocytes from Malawian patients with cerebral malaria-possible modulation in vivo by thrombocytopenia. J Infect Dis (2008) 1.07

Involvement of CD36 on erythrocytes as a rosetting receptor for Plasmodium falciparum-infected erythrocytes. Blood (1992) 1.06

Limited cross-reactivity among domains of the Plasmodium falciparum clone 3D7 erythrocyte membrane protein 1 family. Infect Immun (2006) 1.05

Plasmodium falciparum: the importance of IgM in the rosetting of parasite-infected erythrocytes. Exp Parasitol (1998) 1.03

Variants of Plasmodium falciparum erythrocyte membrane protein 1 expressed by different placental parasites are closely related and adhere to chondroitin sulfate A. J Infect Dis (2001) 1.02

Rosetting is associated with increased Plasmodium falciparum in vivo multiplication rate in the Saimiri sciureus monkey. Microbes Infect (2007) 1.00

Generation of cross-protective antibodies against Plasmodium falciparum sequestration by immunization with an erythrocyte membrane protein 1-duffy binding-like 1 alpha domain. Infect Immun (2006) 0.99

Immune pressure selects for Plasmodium falciparum parasites presenting distinct red blood cell surface antigens and inducing strain-specific protection in Saimiri sciureus monkeys. J Exp Med (1995) 0.99

Rosetting in Plasmodium falciparum: a cytoadherence phenotype with multiple actors. Transfus Clin Biol (2008) 0.99

Platelet-mediated clumping of Plasmodium falciparum infected erythrocytes is associated with high parasitemia but not severe clinical manifestations of malaria in African children. Am J Trop Med Hyg (2007) 0.98

Further definition of PfEMP-1 DBL-1alpha domains mediating rosetting adhesion of Plasmodium falciparum. Mol Biochem Parasitol (2005) 0.96

Multiple human serum components act as bridging molecules in rosette formation by Plasmodium falciparum-infected erythrocytes. Blood (2000) 0.96

Rheological properties of rosettes formed by red blood cells parasitized by Plasmodium falciparum. Br J Haematol (1992) 0.94

Plasmodium falciparum: altered expressions of erythrocyte membrane-associated antigens during antigenic variation. Exp Parasitol (1997) 0.89

Plasmodium falciparumin the squirrel monkey (Saimiri sciureus): infection of non-splenectomised animals as a model for exploring clinical manifestations of malaria. Microbes Infect (2000) 0.87

Receptor-binding studies of the DBLgamma domain of Plasmodium falciparum erythrocyte membrane protein 1 from a placental isolate. Mol Biochem Parasitol (2006) 0.86

Complement factor D, albumin, and immunoglobulin G anti-band 3 protein antibodies mimic serum in promoting rosetting of malaria-infected red blood cells. Infect Immun (2007) 0.85

Functional and immunological characterization of a duffy binding-like- gamma domain from Plasmodium falciparum erythrocyte membrane protein-1 expressed by a placental isolate. J Infect Dis (2005) 0.84

Plasmodium falciparum: genetic diversity of several strains infectious for the squirrel monkey (Saimiri sciureus). Exp Parasitol (1996) 0.83

Induction of cross-reactive immune responses to NTS-DBL-1alpha/x of PfEMP1 and in vivo protection on challenge with Plasmodium falciparum. Vaccine (2006) 0.80

Novel target antigens of the variant-specific immune response to Plasmodium falciparum identified by differential screening of an expression library. Infect Immun (1999) 0.79

A modification in restriction pattern of the Plasmodium falciparum Pf60 multigene family associated with a specific antigenic variation switch in the Palo Alto line. Behring Inst Mitt (1997) 0.79

Articles by these authors

Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet (2005) 8.30

Malaria morbidity and pyrethroid resistance after the introduction of insecticide-treated bednets and artemisinin-based combination therapies: a longitudinal study. Lancet Infect Dis (2011) 7.42

Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies. Lancet Infect Dis (2013) 6.06

Immunoproliferative small intestinal disease associated with Campylobacter jejuni. N Engl J Med (2004) 4.47

Genome-wide and fine-resolution association analysis of malaria in West Africa. Nat Genet (2009) 4.30

An engineered protein tag for multiprotein labeling in living cells. Chem Biol (2008) 3.92

Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J Clin Oncol (2008) 3.75

Worms can worsen malaria: towards a new means to roll back malaria? Trends Parasitol (2005) 3.09

Reduced artemisinin susceptibility of Plasmodium falciparum ring stages in western Cambodia. Antimicrob Agents Chemother (2012) 3.01

Evaluation of an enzyme immunoassay for detection of dengue virus NS1 antigen in human serum. Clin Vaccine Immunol (2006) 2.90

Evaluation of two new commercial tests for the diagnosis of acute dengue virus infection using NS1 antigen detection in human serum. PLoS Negl Trop Dis (2008) 2.79

Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy people. Proc Natl Acad Sci U S A (2010) 2.79

Incidence of tick-borne relapsing fever in west Africa: longitudinal study. Lancet (2006) 2.77

Towards high-throughput molecular detection of Plasmodium: new approaches and molecular markers. Malar J (2009) 2.76

Large-scale malaria survey in Cambodia: novel insights on species distribution and risk factors. Malar J (2007) 2.75

Development and testing of a rapid diagnostic test for bubonic and pneumonic plague. Lancet (2003) 2.68

Long-term clinical protection from falciparum malaria is strongly associated with IgG3 antibodies to merozoite surface protein 3. PLoS Med (2007) 2.54

Crystal structure of the malaria vaccine candidate apical membrane antigen 1. Science (2005) 2.39

Rickettsia felis-associated uneruptive fever, Senegal. Emerg Infect Dis (2010) 2.37

Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: potential role in progression. Genes Chromosomes Cancer (2008) 2.29

Overcoming transcription activator-like effector (TALE) DNA binding domain sensitivity to cytosine methylation. J Biol Chem (2012) 2.25

Increased frequency of malaria attacks in subjects co-infected by intestinal worms and Plasmodium falciparum malaria. Trans R Soc Trop Med Hyg (2003) 2.22

Tropheryma whipplei bacteremia during fever in rural West Africa. Clin Infect Dis (2010) 2.17

The pathogenesis of Plasmodium falciparum malaria in humans: insights from splenic physiology. Blood (2010) 2.17

H-NS cooperative binding to high-affinity sites in a regulatory element results in transcriptional silencing. Nat Struct Mol Biol (2007) 2.08

T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology (2002) 2.06

Clinical relevance of objectifying colposcopy. Arch Gynecol Obstet (2014) 2.03

Ethical issues in human genomics research in developing countries. BMC Med Ethics (2011) 2.02

Evaluation of the VITOM in digital high-definition video exocolposcopy. J Low Genit Tract Dis (2011) 1.87

Quantitative assessment of sensing and sequestration of spherocytic erythrocytes by the human spleen. Blood (2012) 1.87

The RON2-AMA1 interaction is a critical step in moving junction-dependent invasion by apicomplexan parasites. PLoS Pathog (2011) 1.84

Type-dependent integration frequency of human papillomavirus genomes in cervical lesions. Cancer Res (2008) 1.83

A new approach to preserve fertility by using a coated nitinol stent in a patient with recurrent cervical stenosis. Fertil Steril (2006) 1.78

Multicenter validation study of the sentinel lymph node concept in cervical cancer: AGO Study Group. J Clin Oncol (2008) 1.77

Decreased in vitro susceptibility of Plasmodium falciparum isolates to artesunate, mefloquine, chloroquine, and quinine in Cambodia from 2001 to 2007. Antimicrob Agents Chemother (2010) 1.76

Full-length extracellular region of the var2CSA variant of PfEMP1 is required for specific, high-affinity binding to CSA. Proc Natl Acad Sci U S A (2010) 1.73

Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome. Mol Cancer (2003) 1.73

Tick-borne relapsing fever borreliosis, rural senegal. Emerg Infect Dis (2011) 1.73

Identification of a mutant PfCRT-mediated chloroquine tolerance phenotype in Plasmodium falciparum. PLoS Pathog (2010) 1.71

Plasmodium falciparum drug resistance in Madagascar: facing the spread of unusual pfdhfr and pfmdr-1 haplotypes and the decrease of dihydroartemisinin susceptibility. Antimicrob Agents Chemother (2009) 1.70

Laparoscopic-assisted radical vaginal hysterectomy (LARVH): prospective evaluation of 200 patients with cervical cancer. Gynecol Oncol (2003) 1.70

Antibodies to the conserved C-terminal domain of the Plasmodium falciparum merozoite surface protein 1 and to the merozoite extract and their relationship with in vitro inhibitory antibodies and protection against clinical malaria in a Senegalese village. J Infect Dis (2004) 1.70

Analysis of morbidity in patients with endometrial cancer: is there a commitment to offer laparoscopy? Gynecol Oncol (2005) 1.68

The ROP2 family of Toxoplasma gondii rhoptry proteins: proteomic and genomic characterization and molecular modeling. Proteomics (2006) 1.64

Solid neuroendocrine carcinomas of the breast: metastases or primary tumors? Breast Cancer Res Treat (2010) 1.63

Residues in the HIV-1 capsid assembly inhibitor binding site are essential for maintaining the assembly-competent quaternary structure of the capsid protein. J Biol Chem (2008) 1.61

Retention of Plasmodium falciparum ring-infected erythrocytes in the slow, open microcirculation of the human spleen. Blood (2008) 1.58

Common epidemiology of Rickettsia felis infection and malaria, Africa. Emerg Infect Dis (2013) 1.54

Promoter hypermethylation of FANCF: disruption of Fanconi Anemia-BRCA pathway in cervical cancer. Cancer Res (2004) 1.53

Field evaluation of a rapid immunochromatographic dipstick test for the diagnosis of cholera in a high-risk population. BMC Infect Dis (2006) 1.53

Investigating the host binding signature on the Plasmodium falciparum PfEMP1 protein family. PLoS Pathog (2011) 1.53

The sensing of poorly deformable red blood cells by the human spleen can be mimicked in vitro. Blood (2010) 1.52

Invasion of Africa by a single pfcrt allele of South East Asian type. Malar J (2006) 1.51

Structural comparison of apical membrane antigen 1 orthologues and paralogues in apicomplexan parasites. Mol Biochem Parasitol (2005) 1.51

The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease. Am J Gastroenterol (2010) 1.50

Gene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genes. Genes Chromosomes Cancer (2007) 1.50

In vitro monitoring of Plasmodium falciparum drug resistance in French Guiana: a synopsis of continuous assessment from 1994 to 2005. Antimicrob Agents Chemother (2007) 1.49

Community-acquired infectious diarrhoea in children under 5 years of age in Dakar, Senegal. Paediatr Int Child Health (2013) 1.49

HPV vaccination against cervical cancer in women above 25 years of age: key considerations and current perspectives. Gynecol Oncol (2009) 1.48

New paradigm for prevention of cervical cancer. Eur J Obstet Gynecol Reprod Biol (2006) 1.48

Fine mapping of an epitope recognized by an invasion-inhibitory monoclonal antibody on the malaria vaccine candidate apical membrane antigen 1. J Biol Chem (2006) 1.47

Clinical protection from falciparum malaria correlates with neutrophil respiratory bursts induced by merozoites opsonized with human serum antibodies. PLoS One (2010) 1.46

Early and strong immune responses are associated with control of viral replication and recovery in lassa virus-infected cynomolgus monkeys. J Virol (2009) 1.45

Structural and functional insights into the malaria parasite moving junction complex. PLoS Pathog (2012) 1.44

Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression. Mol Cancer (2006) 1.44

Point-of-care laboratory of pathogen diagnosis in rural Senegal. PLoS Negl Trop Dis (2013) 1.44

Rapid dissemination of Plasmodium falciparum drug resistance despite strictly controlled antimalarial use. PLoS One (2007) 1.44

Re-evaluation of how artemisinins work in light of emerging evidence of in vitro resistance. Trends Mol Med (2006) 1.42

Use of dipsticks for rapid diagnosis of cholera caused by Vibrio cholerae O1 and O139 from rectal swabs. J Clin Microbiol (2003) 1.42

Laparoscopic pelvic lymphadenectomy in 32 pregnant patients with cervical cancer: rationale, description of the technique, and outcome. Int J Gynecol Cancer (2014) 1.41

Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma. BMC Cancer (2004) 1.40

A role for the Plasmodium falciparum RESA protein in resistance against heat shock demonstrated using gene disruption. Mol Microbiol (2005) 1.39

Cyclodimerization of an oxoboryl complex induced by trans ligand abstraction. Angew Chem Int Ed Engl (2010) 1.39

Ex vivo perfusion of human spleens maintains clearing and processing functions. Blood (2005) 1.39

Reemergence of dengue virus type 4, French Antilles and French Guiana, 2004-2005. Emerg Infect Dis (2006) 1.36

Evaluation of three rapid diagnostic tests for cholera: does the skill level of the technician matter? Trop Med Int Health (2006) 1.36

Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15-55 years. Vaccine (2008) 1.35

A new Apicomplexa-specific protein kinase family: multiple members in Plasmodium falciparum, all with an export signature. BMC Genomics (2005) 1.34

Changing malaria epidemiology and diagnostic criteria for Plasmodium falciparum clinical malaria. PLoS One (2012) 1.33

Laparoscopy versus laparotomy in endometrial cancer: first analysis of survival of a randomized prospective study. J Minim Invasive Gynecol (2005) 1.32

Use of HRP-2-based rapid diagnostic test for Plasmodium falciparum malaria: assessing accuracy and cost-effectiveness in the villages of Dielmo and Ndiop, Senegal. Malar J (2010) 1.31

The majority of viral-cellular fusion transcripts in cervical carcinomas cotranscribe cellular sequences of known or predicted genes. Cancer Res (2008) 1.30

Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha. Mol Cancer (2008) 1.29

Multinormal in vitro distribution model suitable for the distribution of Plasmodium falciparum chemosusceptibility to doxycycline. Antimicrob Agents Chemother (2008) 1.29

Structural basis for the ABO blood-group dependence of Plasmodium falciparum rosetting. PLoS Pathog (2012) 1.27

Differentiation of phyllodes breast tumors from fibroadenomas on MRI. AJR Am J Roentgenol (2005) 1.27

Retention of erythrocytes in the spleen: a double-edged process in human malaria. Curr Opin Hematol (2009) 1.27